Company / Depreciation & Amortization
IDEAYA Biosciences, Inc. Depreciation & Amortization History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$2.7M
FY2025
5-year range
$1.2M / $2.7M
FY2021-FY2025
Trend
+13.1%
vs FY2024
Sector context
#89 of 163
Health Care
What the data says
At $3M, IDEAYA Biosciences, Inc.'s depreciation & amortization ranks #75 of 163 in the Health Care sector. Depreciation & Amortization has fluctuated over the past 9 years, ranging from $391,000 in FY2017 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +25.0%.
Increased from $2M to $3M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +25.0%
- 5-Year CAGR
- +25.0%
- 10-Year CAGR
- -
Sector benchmark
#75 of 163 in Health CareTop 45% of 163This company $2.7M Sector average $219.4M
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +25.0%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 13.1% year-over-year.
- Ranks #89 out of 163 companies in the Health Care sector.
- Lowest depreciation & amortization in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.7M | +13.1% |
| FY2024 | $2.4M | -3.6% |
| FY2023 | $2.5M | +79.3% |
| FY2022 | $1.4M | +10.9% |
| FY2021 | $1.2M | +40.5% |
| FY2020 | $886.0K | -36.7% |
| FY2019 | $1.4M | +58.0% |
| FY2018 | $886.0K | +126.6% |
| FY2017 | $391.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026